+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cell Therapy Market Intelligence Report - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 178 Pages
  • January 2023
  • Region: Global
  • Think Market Intelligence
  • ID: 5670010
UP TO OFF until Mar 31st 2023
The Global Cell Therapy Market is projected to reach USD 17,914.75 million by 2030 from USD 7,822.01 million in 2022, at a CAGR 10.91% during the forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions.

In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

  • The Americas Cell Therapy Market size was estimated at USD 2,846.31 million in 2022 and expected to reach USD 3,150.88 million in 2023, at a CAGR 10.89% to reach USD 6,509.86 million by 2030.
  • The Asia-Pacific Cell Therapy Market size was estimated at USD 1,965.79 million in 2022 and expected to reach USD 2,190.66 million in 2023, at a CAGR 11.07% to reach USD 4,556.08 million by 2030.
  • The Europe, Middle East & Africa Cell Therapy Market size was estimated at USD 3,009.91 million in 2022 and expected to reach USD 3,323.46 million in 2023, at a CAGR 10.82% to reach USD 6,848.81 million by 2030.

Market Segmentation & Coverage:

The report on the Global Cell Therapy Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan.

This research report categorizes the Global Cell Therapy Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Cell Type:

  • Differentiated Cell
  • Stem Cell

Therapy Type:

  • Allogenic Therapies
  • Autologous Therapies

Application:

  • Autoimmune Diseases
  • Dermatology
  • Musculoskeletal Therapies
  • Oncology

End-User:

  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Clinics
  • Research Institutes

Region:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

Company Usability Profiles:

  • Anterogen Co., Ltd.
  • Astellas Pharma Inc.
  • BioNTech SE
  • Bristol-Myers Squibb Company
  • Castle Creek Biosciences, Inc.
  • FUJIFILM Holdings Corporation
  • Gilead Sciences, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Kolon TissueGene, Inc.
  • Lonza Group Ltd.
  • Medipost Co., Ltd.
  • Novartis AG
  • NuVasive, Inc.
  • Pfizer Inc.
  • Sartorius AG
  • Smith & Nephew PLC
  • Stemedica Cell Technologies, Inc.
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific, Inc.
  • Vericel Corporation
Frequently Asked Questions about the Global Cell Therapy Market

What is the estimated value of the Global Cell Therapy Market?

The Global Cell Therapy Market was estimated to be valued at $7822.01 Million in 2022.

What is the growth rate of the Global Cell Therapy Market?

The growth rate of the Global Cell Therapy Market is 10.9%, with an estimated value of $17914.75 Million by 2030.

What is the forecasted size of the Global Cell Therapy Market?

The Global Cell Therapy Market is estimated to be worth $17914.75 Million by 2030.

Who are the key companies in the Global Cell Therapy Market?

Key companies in the Global Cell Therapy Market include Anterogen Co., Ltd., Astellas Pharma Inc., BioNTech SE, Bristol, Myers Squibb Company, Castle Creek Biosciences, Inc., FUJIFILM Holdings Corporation, Gilead Sciences, Inc. and Kolon TissueGene, Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Market Overview

4. Americas Cell Therapy Market
4.1. Introduction
4.2. Argentina
4.3. Brazil
4.4. Canada
4.5. Mexico
4.6. United States

5. Asia-Pacific Cell Therapy Market
5.1. Introduction
5.2. Australia
5.3. China
5.4. India
5.5. Indonesia
5.6. Japan
5.7. Malaysia
5.8. Philippines
5.9. Singapore
5.10. South Korea
5.11. Taiwan
5.12. Thailand
5.13. Vietnam

6. Europe, Middle East & Africa Cell Therapy Market
6.1. Introduction
6.2. Denmark
6.3. Egypt
6.4. Finland
6.5. France
6.6. Germany
6.7. Israel
6.8. Italy
6.9. Netherlands
6.10. Nigeria
6.11. Norway
6.12. Poland
6.13. Qatar
6.14. Russia
6.15. Saudi Arabia
6.16. South Africa
6.17. Spain
6.18. Sweden
6.19. Switzerland
6.20. Turkey
6.21. United Arab Emirates
6.22. United Kingdom

7. Competitive Landscape
7.1. FPNV Positioning Matrix
7.1.1. Quadrants
7.1.2. Business Strategy
7.1.3. Product Satisfaction
7.2. Market Ranking Analysis, By Key Player
7.3. Market Share Analysis, By Key Player
7.4. Product Portfolio Analysis, By Key Player
7.5. Competitive Scenario
7.5.1. Merger & Acquisition
7.5.2. Agreement, Collaboration, & Partnership
7.5.3. New Product Launch & Enhancement
7.5.4. Investment & Funding
7.5.5. Award, Recognition, & Expansion

8. Company Usability Profiles
8.1. Anterogen Co., Ltd.
8.2. Astellas Pharma Inc.
8.3. BioNTech SE
8.4. Bristol-Myers Squibb Company
8.5. Castle Creek Biosciences, Inc.
8.6. FUJIFILM Holdings Corporation
8.7. Gilead Sciences, Inc.
8.8. JCR Pharmaceuticals Co., Ltd.
8.9. Kolon TissueGene, Inc.
8.10. Lonza Group Ltd.
8.11. Medipost Co., Ltd.
8.12. Novartis AG
8.13. NuVasive, Inc.
8.14. Pfizer Inc.
8.15. Sartorius AG
8.16. Smith & Nephew PLC
8.17. Stemedica Cell Technologies, Inc.
8.18. Takeda Pharmaceutical Company Limited
8.19. Thermo Fisher Scientific, Inc.
8.20. Vericel Corporation

9. Appendix
9.1. Discussion Guide
9.2. License & Pricing


List of Figures
FIGURE 1. GLOBAL CELL THERAPY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 4. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CELL THERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 6. GLOBAL CELL THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 7. GLOBAL CELL THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CELL THERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 9. AMERICAS CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 10. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 11. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS CELL THERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 13. ARGENTINA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 14. BRAZIL CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 15. CANADA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 16. MEXICO CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 17. UNITED STATES CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 19. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES CELL THERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 21. ASIA-PACIFIC CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC CELL THERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 25. AUSTRALIA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 26. CHINA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 27. INDIA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 28. INDONESIA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 29. JAPAN CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 30. MALAYSIA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 31. PHILIPPINES CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 32. SINGAPORE CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 33. SOUTH KOREA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 34. TAIWAN CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 35. THAILAND CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 36. VIETNAM CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 37. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 38. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 40. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 41. DENMARK CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 42. EGYPT CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 43. FINLAND CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. FRANCE CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. GERMANY CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 46. ISRAEL CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 47. ITALY CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 48. NETHERLANDS CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 49. NIGERIA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. NORWAY CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 51. POLAND CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 52. QATAR CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 53. RUSSIA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. SAUDI ARABIA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 55. SOUTH AFRICA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 56. SPAIN CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 57. SWEDEN CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 58. SWITZERLAND CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 59. TURKEY CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. UNITED KINGDOM CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. GLOBAL CELL THERAPY MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 63. GLOBAL CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 64. GLOBAL CELL THERAPY MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL CELL THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. AMERICAS CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 7. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 8. AMERICAS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 9. AMERICAS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 10. AMERICAS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. AMERICAS CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 12. ARGENTINA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 13. ARGENTINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 14. ARGENTINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 15. ARGENTINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 17. BRAZIL CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. CANADA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 23. CANADA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 24. CANADA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 25. CANADA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. CANADA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. MEXICO CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 28. MEXICO CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 29. MEXICO CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 30. MEXICO CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. MEXICO CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. AUSTRALIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. CHINA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 50. CHINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 51. CHINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 52. CHINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. CHINA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. INDIA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 55. INDIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 56. INDIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 57. INDIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. INDIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. INDONESIA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 60. INDONESIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 61. INDONESIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. JAPAN CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 65. JAPAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 66. JAPAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 67. JAPAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. JAPAN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. MALAYSIA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. PHILIPPINES CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. THAILAND CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 95. THAILAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 96. THAILAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 97. THAILAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. THAILAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. DENMARK CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 111. DENMARK CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 112. DENMARK CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 113. DENMARK CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. DENMARK CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. EGYPT CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 116. EGYPT CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 117. EGYPT CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 118. EGYPT CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. EGYPT CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. FINLAND CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 121. FINLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 122. FINLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 123. FINLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. FINLAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. FRANCE CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 126. FRANCE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 127. FRANCE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 128. FRANCE CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. FRANCE CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. GERMANY CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 131. GERMANY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 132. GERMANY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 133. GERMANY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. GERMANY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. ISRAEL CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 136. ISRAEL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 137. ISRAEL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 138. ISRAEL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. ISRAEL CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. ITALY CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 141. ITALY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 142. ITALY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 143. ITALY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. ITALY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 146. NETHERLANDS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 147. NETHERLANDS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 148. NETHERLANDS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. NETHERLANDS CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. NIGERIA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 151. NIGERIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 152. NIGERIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 153. NIGERIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. NIGERIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. NORWAY CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 156. NORWAY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 157. NORWAY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 158. NORWAY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. NORWAY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. POLAND CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 161. POLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 162. POLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 163. POLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. POLAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. QATAR CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 166. QATAR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 167. QATAR CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 168. QATAR CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. QATAR CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. SPAIN CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 186. SPAIN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 187. SPAIN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 188. SPAIN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. SPAIN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. SWEDEN CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 191. SWEDEN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 192. SWEDEN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 193. SWEDEN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. SWEDEN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. SWITZERLAND CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 198. SWITZERLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. SWITZERLAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. TURKEY CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 201. TURKEY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 202. TURKEY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 203. TURKEY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. TURKEY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. GLOBAL CELL THERAPY MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 216. GLOBAL CELL THERAPY MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 217. GLOBAL CELL THERAPY MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 218. GLOBAL CELL THERAPY MARKET RANKING, BY KEY PLAYER, 2022
TABLE 219. GLOBAL CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2022
TABLE 220. GLOBAL CELL THERAPY MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 221. GLOBAL CELL THERAPY MARKET MERGER & ACQUISITION
TABLE 222. GLOBAL CELL THERAPY MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 223. GLOBAL CELL THERAPY MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 224. GLOBAL CELL THERAPY MARKET INVESTMENT & FUNDING
TABLE 225. GLOBAL CELL THERAPY MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 226. GLOBAL CELL THERAPY MARKET: LICENSE & PRICING

Companies Mentioned

  • Anterogen Co., Ltd.
  • Astellas Pharma Inc.
  • BioNTech SE
  • Bristol-Myers Squibb Company
  • Castle Creek Biosciences, Inc.
  • FUJIFILM Holdings Corporation
  • Gilead Sciences, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Kolon TissueGene, Inc.
  • Lonza Group Ltd.
  • Medipost Co., Ltd.
  • Novartis AG
  • NuVasive, Inc.
  • Pfizer Inc.
  • Sartorius AG
  • Smith & Nephew PLC
  • Stemedica Cell Technologies, Inc.
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific, Inc.
  • Vericel Corporation

Methodology

Loading
LOADING...